Mr. Kiyoshiro Tanaka received master’s degree of medical science, specialized in biostatistics, in 2021 from Kurume University. Since 2021, Mr. Tanaka has been serving as a biostatistical reviewer in the New Drug Department at PMDA. He has contributed to the Guidelines for Clinical Evaluation of Chronic Kidney Disease in Early Stages in Japan (to be published in 2024).